유리피판술에서 덱스트란의 사용이 필요한가?

Is It Necessary to Use Dextran in Free Flap Surgery?

  • 안희창 (한양대학교 의과대학 성형외과학 교실) ;
  • 김기웅 (한양대학교 의과대학 성형외과학 교실) ;
  • 이영진 (한양대학교 의과대학 성형외과학 교실) ;
  • 김연환 (한양대학교 의과대학 성형외과학 교실)
  • Ahn, Hee Chang (Department of Plastic and Reconstructive Surgery, College of Medicine, Hanyang University) ;
  • Kim, Kee Woong (Department of Plastic and Reconstructive Surgery, College of Medicine, Hanyang University) ;
  • Lee, Young Jin (Department of Plastic and Reconstructive Surgery, College of Medicine, Hanyang University) ;
  • Kim, Yeon Hwan (Department of Plastic and Reconstructive Surgery, College of Medicine, Hanyang University)
  • 발행 : 2009.07.15

초록

Purpose: Low - molecular - weight dextran is one of the most frequently used antithrombotic agents in microvascular surgery, but there is controversy if it has the real benefit in the clinical aspects. The purpose of this study was to evaluate the effect associated with postoperative use of low - molecular - weight dextran in breast reconstruction by free TRAM flap patients. Methods: From January 2002 to October 2008, we reconstructed 88 cases of postmastectomy deformity using the free TRAM flap. The 88 cases were divided into two groups : a group with no use of dextran(66 patients, control group, Group A) and a postoperative low - molecular weight dextran loaded group(22 patients, Group B). We assessed number of flap survival, rate of complication like hematoma or seroma, total amount of drainage from operative wound, duration of drainage, and amount of transfusion in each group. Results: There was no total flap loss and every flap was survived. Total amount of drainage for post - operative 5 days were 857 ml in group A and 1101 ml in group B. Drain was kept for average of 7.3 days in group A and 8.7 days in group B. Packed red cell transfusions were made in average of 3.3 units for group A and 3.0 units for group B. Group B showed significantly higher values in former 2 comparative parameters than group A. Conclusion: There was no definitive advantage of anticoagulants in elective free - flap surgery in terms of success rate. However, groups with using anticoagulants had the increased bleeding tendency in immediate postoperative period. The routine use of anticoagulants in elective free - flap surgery should be reconsidered with postoperatively less bleeding and early recovery.

키워드

참고문헌

  1. Khouri RK: Avoiding free flap failure. Clin Plast Surg 19: 773, 1992
  2. Kroll SS, Schusterman MA, Reece GP, Miller MJ, Evans GR, Robb GL, Baldwin BJ: Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plast Reconstr Surg 98: 1230, 1996 https://doi.org/10.1097/00006534-199612000-00017
  3. Disa JJ, Cordeiro PG, Hidalgo DA: Efficacy of conventional monitoring techniques in free tissue transfer: an 11-year experience in 750 consecutive cases. Plast Reconstr Surg 104: 97, 1999 https://doi.org/10.1097/00006534-199907000-00013
  4. Johnson PC, Barker JH: Thrombosis and antithrombotic therapy in microvascular surgery. Clin Plast Surg 19: 799, 1992
  5. Wieslander JB, Dougan P, Stjernquist U, Aberg M, Bergentz SE: The influence of dextran and saline solution upon platelet behavior after microarterial anastomosis. Surg Gynecol Obstet 163: 256, 1986
  6. Kroll SS, Miller MJ, Reece GP, Baldwin BJ, Robb GL, Bengtson BP, Phillips MD, Kim D, Schusterman MA: Anticoagulants and hematomas in free flap surgery. Plast Reconstr Surg 96: 643, 1995 https://doi.org/10.1097/00006534-199509000-00017
  7. Rothkopf DM, Chu B, Bern S, May JW Jr: The effect of dextran on microvascular thrombosis in an experimental rabbit model. Plast Reconstr Surg 92: 511, 1993 https://doi.org/10.1097/00006534-199309000-00021
  8. Davidson SF, Brantley SK, Das SK: Comparison of single-dose antithrombotic agents in the prevention of microvascular thrombosis. J Hand Surg [Am] 16: 585, 1991 https://doi.org/10.1016/0363-5023(91)90177-D
  9. Salemark L, Wieslander JB, Dougan P, Arnljots B: Studies of the antithrombotic effects of dextran 40 following microarterial trauma. Br J Plast Surg 44: 15, 1991 https://doi.org/10.1016/0007-1226(91)90170-O
  10. Thorsen G: The use of dextrans as infusion fluids. Surg Gynecol Obstet 109: 43, 1959
  11. Maddi VI, Wyso EM, Zinner EN: Dextran anaphylaxis. Angiology 20: 243, 1969 https://doi.org/10.1177/000331976902000502
  12. Hein KD, Wechsler ME, Schwartzstein RM, Morris DJ: The adult respiratory distress syndrome after dextran infusion as an antithrombotic agent in free TRAM flap breast reconstruction. Plast Reconstr Surg 103: 1706, 1999 https://doi.org/10.1097/00006534-199905060-00022
  13. Brooks D, Okeefe P, Buncke HJ: Dextran-induced acute renal failure after microvascular muscle transplantation. Plast Reconstr Surg 108: 2057, 2001 https://doi.org/10.1097/00006534-200112000-00034
  14. Disa JJ, Polvora VP, Pusic AL, Singh B, Corderiro PG: Dextran-related complications in head and neck microsurgery: do the benefits outweigh the risks-a prospective randomized analysis. Plast Reconstr Surg 112: 1534, 2003 https://doi.org/10.1097/01.PRS.0000083378.58757.54